CCAAT/enhancer-binding protein (C/EBP) β regulates chondrocyte differentiaion and proliferation during endochondral ossification. However, expression and function of other C/EBP family members in chondrocytes have not been fully understood. To understand the comprehensive regulation of chondrocyte differentiation by C/EBPs, we initially examined their expression levels. Among four members (C/EBPα, C/EBPβ, C/EBPδ and C/EBPε) with transactivation domain, expression of Cebpb and Cebpd was abundant compared to Cebpa, while Cebpe was hardly expressed in mouse isolated chondrocytes. Doxycycline (DOX)-inducible overexpression of each of the three C/EBPs (C/EBPα, C/EBPβ and C/EBPδ) in ATDC5 cells suppressed expressions of early differentiation markers including Col2a1, aggrecan and Sox9, enhanced those of late differentiation markers including Mmp13, Vegfa and Col10a1, and decelerated cell proliferation, indicating their overlapped functions in chondrocytes. In contrast, DOX-inducible overexpression of A-CEBP, which exerts a dominant-negative effect against all C/EBPs, increased expressions of early differentiation markers and decreased those of late differentiation markers. Finally, microarray and gene ontology analyses showed that A-CEBP altered many genes related with various events or tissues such as skeletal development, cartilage, cell cycle, inflammation and apoptosis. In conclusion, C/EBPα, C/EBPβ and C/EBPδ regulate proliferation and differentiation of chondrocytes and possibly is involved with apoptosis and inflammation. C/EBPs may play a variety of roles in the homeostasis of joint cartilage under physiological and pathological conditions. In skeletal growth, the endochondral ossification plays an essential role. Initially, undifferentiated mesenchymal cells condense and form cartilage anlagen (20). Cells of condensations become immature chondrocytes and enlarge cartilage through proliferation and matrix production including type II collagen (Col2a1) and aggrecan (20). Chondrocytes then undergo hypertrophic differentiation which is characterized by cell cycle arrest, enlargement of cell size, and production of type X collagen (Col10a1) (20). Hypertrophic chondrocytes also secrete high levels of vascular endothelial growth factor (VEGF), which induces vascular invasion (22). In the terminal stage, proteases such as matrix metallopeptidase 13 (Mmp13) are produced and break down cartilage matrix to promote bone formation. These sequential steps of the endochondral ossification are regulated by various molecules and signaling pathways including sex-determining region Y-type high mobility group box protein 9 (Sox9), runt related transcrip-
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MATERIALS AND METHODS

Real-time RT-PCR.
Primary costal and articular chondrocytes were isolated from wild-type C57BL/6J mice (E18.5 and 6-days-old, respectively) (7). Total RNA was extracted from the chondrocytes using RNeasy mini kits (Qiagen) according to the manufacturer's protocol. Real-time RT-PCR was performed using an Mx3000P (Agilent Technologies) and FastStart Universal SYBR Green Master (Roche). All animal experiments were undertaken according to the guidelines of the Animal Care and Use Committee of the University of Tokyo, and that of the Institute of Laboratory Animal Resources' Guide for the Care and Use of Laboratory Animals of USA.
Histological analyses. Proximal tibia of mouse embryo (E18.5) was harvested, fixed with 4% paraformaldehyde for 24 h, and 5-μm paraffin-embedded sections were prepared. H&E staining was performed as the standard protocol. For immunofluorescence, after deparaffinization and blocking with 3% BSA in PBS, the sections were incubated with antibodies to Cebpa (1 : 100; Santa Cruz Biotechnology, rabbit polyclonal antibody raised against a peptide of human CEBPA, with cross-reactivity to mouse homolog), Cebpb (1 : 100; Abcam, rabbit monoclonal antibody raised against a peptide of rat Cebpb, with cross-reactivity to mouse homolog) or Cebpd (1 : 100; Santa Cruz Biotechnology, rabbit polyclonal antibody raised against a peptide of human CEBPD, with cross-reactivity to mouse homolog). We detected the signal with a TSA Plus Fluorescence System (PerkinElmer, Shelton, CT).
Construction of expression vectors.
We cloned cDNA of each C/EBP into pcDNA3.1 (Invitrogen). A-CEBP, a dominant-negative form specific to C/EBP family members (8), was artificially synthesized and cloned into pcDNA3.1. Doxycycline (DOX)-inducible lentiviruses were prepared using Tet-On 3G system (Clontech) and pLenti6.3 (Invitrogen), and packaged in Lenti-X 293T cells (Clontech).
Cell culture. HeLa cells (RIKEN BRC) were cultured in high-glucose DMEM with 10% FBS, penicillin (100 U/mL), and streptomycin (100 mg/mL). The chondrogenic cell line ATDC5 (RIKEN BRC) was cultured in DMEM/F-12 with 5% FBS, penicillin (100 U/mL), and streptomycin (100 mg/mL). To induce differentiation, ATDC5 cells were cultured in the presence of ITS (insulin, transferrin and sodium selenite) supplement for 3 weeks and then cultured tion factor 2 (Runx2), indian hedgehog (Ihh), parathyroid hormone-related protein (PTHrP), fibroblast growth factor (FGF), and Wnt signaling (20) . CCAAT/enhancer-binding proteins (C/EBP) are transcription factors characterized by a carboxyl-terminal leucine zipper dimerization domain and an adjacent highly conserved basic DNA binding domain (4, 21, 24, 29) . These two domains are designated as a basic-leucine zipper (bZIP) domain with sequence identity shared by all C/EBPs (>90%) in the C-terminal 55-65 amino acid residues (24, 29, 38) . In contrast, the N-termini are quite divergent (<20%, sequence identity), except some short regions that represent a transactivation domain (TAD) (24, 29) . The C/EBP family consists of six isoforms: C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ, C/EBPε, and C/EBPζ (29, 38). Among them, C/EBPα, C/EBPβ, C/EBPδ, and C/EBPε have a TAD (29, 38) . Some of the four C/EBP proteins are co-expressed and cooperatively regulate differentiation of different kinds of cells or tissues (29, 38) . We previously reported that C/EBPβ regulates chondrocyte proliferation during endochondral ossification (12). C/EBPβ also represses the expression of Col2a1, and promotes terminal differentiation of chondrocytes through induction of Mmp13 and VEGF with GADD45β and Runx2 (12, 13, 37, 39) . However, C/EBPβ null (Cebpb−/−) mice exhibited slight impairment of skeletal growth (12), and deficient mice of other C/EBPs showed no gross abnormalities in appearance at birth (17, 28, 34, 40) . Meanwhile, double knockout mice of C/EBPs show more remarkable phenotypes than single knockout mice, e.g., impaired adipocyte differentiation in Cebpb−/− & Cebpd−/− mice, and defective myeloid differentiation in Cebpb−/− & Cebpe−/− mice (1, 35). These previous data may indicate that functions of several C/EBPs are overlapped in chondrocyte differentiation, and that deficiency of C/EBPβ is masked by other family members in Cebpb−/− mice. However, skeletal development has not been examined in these double knockout mice, and functions of C/EBP family members other than C/EBPβ are unknown. In the present study, to determine the comprehensive regulation of chondrocyte differentiation by C/ EBP family members, we examined expression of C/EBPs and gain-of-function of each member in chondrocytes. We further analyzed loss-of-function of C/EBPs using a C/EBP-specific dominant-negative form, and showed altered gene expressions when all C/EBPs were inhibited. detected throughout the embryonic limb cartilage (Fig. 1C, D) .
Effects of C/EBPα, C/EBPβ and C/EBPδ in chondrocyte differentiation
To examine effects of the three C/EBPs in each step of chondrocyte differentiation, we generated ATDC5 cells which express Cebpa, Cebpb, Cebpd or GFP after DOX induction by lentiviral introduction. When we differentiated them for 2 weeks after DOX induction, Col2a1, aggrecan and Sox9 were suppressed by all three C/EBPs ( Fig. 2A) . In contrast, when we started DOX induction 2 weeks after initiation of the differentiation and cultured them for one additional week, Mmp13, Vegfa and Col10a1 were enhanced by C/EBP overexpression (Fig. 2B) . Alcian blue and Alizarin red S stainings were consistent with suppressed chondrogenic and enhanced hypertrophic differentiation markers, respectively (Fig. 2C ). Cell proliferation determined by CCK-8 was significantly decreased by all three C/EBPs (Fig. 2D) .
Dominant-negative effects of A-CEBP to C/EBPα, C/EBPβ and C/EBPδ
We next analyzed loss-of-function of C/EBPα, C/ EBPβ and C/EBPδ in the same cell culture system. We focused on A-CEBP, an artificial construct that works as a dominant-negative form by heterodimerizing with C/EBP proteins and deleting their DNAbinding ability (8). High binding affinity between A-CEBP and each C/EBP was shown by mammalian two-hybrid assay (Fig. 3A) . Co-immunoprecipiation assay confirmed their protein-protein bindings (Fig. 3B) . We further examined dominant-negative effects of A-CEBP to C/EBPs by luciferase assay. MMP13 and VEGFA promoters were markedly transactivated by the three C/EBPs (Fig. 3C ). Co-transfection of A-CEBP suppressed transactivation of both promoters by C/EBPβ in a dose-dependent manner (Fig. 3C ).
Effects of a dominant-negative C/EBP in chondrocyte differentiation
To examine loss-of-function of the three C/EBPs, we generated ATDC5 cells which express A-C/EBP after DOX induction by lentiviral introduction. When we differentiated them for 2 weeks after DOX induction, Col2a1 expression was enhanced by A-CEBP overexpression, while increase of aggrecan and Sox9 was slight (Fig. 4A) . In contrast, when we started DOX induction at 2 weeks, Mmp13, Vegfa, and Col10a1 were suppressed (Fig. 4B ). Alcian blue staining was slightly enhanced, and Alizarin red S in α-MEM with 5% FBS and 4 mM inorganic phosphate (Pi) for 2 additional days, as previously described (30) . Stable and DOX-inducible ATDC5 cells were established as previously described (43), and cultured with 2 μg/mL DOX to activate the Tet-On inducible expression system. Alcian blue and Alizarin red S stainings were performed as previously described (30) . We assessed cell proliferation using a Cell Counting Kit-8 (CCK-8) assay kit (Dojindo, Kumamoto, Japan) according to the manufacturer's instructions.
Co-immunoprecipitation assay. We prepared 3xFLAG-tagged A-CEBP by cloning A-CEBP into pCMV3tag (Agilent), and 3xHA-tagged C/EBPs by cloning 3xHA into pcDNA3.1. FLAG-tagged vector and HAtagged vector were co-transfected into HeLa cells, and cell lysates were collected after 2 days. Co-immunoprecipitation assay was performed as previously described (31) .
Microarray analysis. cDNA microarray analysis was performed using total RNA from ATDC5 cells overexpressing GFP or A-CEBP after 3-week-differentiation. We used SurePrint G3 Mouse GE 8x60K Microarray (Agilent). Genes which had more than 2-fold change were listed as down-or up-regulated. The results of the present microarray analysis have been deposited in Gene Expression Omnibus (http://www.ncbi.nlm. nih.gov/geo/) under accession number GSE60651.
Statistical analyses. Statistical analyses were performed using the Student's two-tailed t-test with significance set at P < 0.05, P < 0.01 or P < 0.005.
RESULTS
Expression of C/EBP family members in chondrocytes
We initially examined expression of four C/EBP family members with TAD in mouse primary costal chondrocytes. Expression of Cebpb and Cebpd was abundant compared to Cebpa, while Cebpe was hardly detected at the mRNA level (Fig. 1A) . During differentiation of mouse chondrogenic cell lines ATDC5, Cebpb and Cebpd were increased in the late stage, whereas Cepba was increased in the early stage (Fig. 1B) . We next examined expression patterns of Cebpa, Cebpb and Cebpd in limb cartilage of mouse embryo (E18.5) by immunofluorescence. Cebpa protein was weakly expressed from periarticular to proliferative zone, and hardly detected in hypertrophic zone (Fig. 1C, D) . Cebpb and Cebpd proteins were staining was suppressed by A-CEBP overexpression, consistently with the results of real-time RT-PCR (Fig. 4C ). Cell proliferation was enhanced by A-CEBP overexpression (Fig. 4D ). Table S1 -10).
Altered gene expressions by A-CEBP
DISCUSSION
In the present study, we showed expressions of C/ EBP family members with TAD in differentiating chondrocytes. C/EBPα, C/EBPβ, and C/EBPδ, which are expressed in chondrocytes, have similar functions to suppress expression of chondrogenic marker genes and cell proliferation, and to enhance expression of hypertrophic differentiation marker genes. In the previous studies, the overlapped functions of C/EBPβ and C/EBPδ in response to IL-1β were described (25, 36). However, functions, expression levels and patterns of C/EBP family members in chondrocytes have not been widely compared in the same experiments. The present data revealed the similar functions of the three C/EBPs in various steps of cultured chondrocytes. Compensation by these family members may make it difficult to analyze the in vivo roles of C/EBP genes by generating single or double knockout mice. In contrast to their common effects in chondrocytes, we found no specific effect of each C/EBP. The further combination of gain-of-function and loss-of-function studies may be necessary to address this issue.
A-CEBP was designed as a dominant-negative form which heterodimerizes promiscuously with all C/EBPs but not with other basic leucine zipper families like CREB (8). A-CEBP overexpression in ATDC5 cells resulted in contrary effects to those by the C/EBPs ( Fig. 4A-D) . However, the alterations of the marker genes were up to twice at most; this may be due to other potent transcription factors or signal pathways which regulate them; e.g., Hif2a, Runx2, and Notch signaling for Mmp13 induction (13, 14, 31) . The microarray analysis identified many genes which may be regulated by C/EBPs in various essential processes such as skeletal development, cell proliferation, inflammation and apoptosis. Notably, (error bars). *P < 0.05, **P < 0.01, ***P < 0.005 versus GFP.
previous studies using Cebpb-deficient mice (9, 11, 12, 33) . The microarray data imply that cell cycle regulation by the C/EBPs is also mediated by various target genes, such as Fgf signaling and Foxo4-p21 cip1 axis (Supplemental Table S4 , S6) (2). Anabolic gene expressions including Col2a1, aggrecan, and Sox9 were also suppressed by the three C/EBPs, and enhanced by A-CEBP ( Fig. 2A, 4A) . Notably, alteration of Col2a1 was larger than that of Sox9 in both experiments. These data are consistent with the previous study, which described that C/ EBPβ represses Col2a1 transcription both directly and indirectly through modulation of Sox9 expression (39). A recent study showed reciprocal repression of Sox9 and C/EBPα in hepatocytes (27) . These data imply mutual negative regulation of Sox9 and C/EBP family members during the endochondral ossification process. As for target genes in chondrocytes other than Col2a1, cartilage-derived retinoic acid-sensitive protein (CD-RAP), coded by melanoma inhibitory activity (MIA), is repressed by C/ EBPβ and C/EBPδ (25). CD-RAP is a small secreted protein which is associated with organization of several genes were markedly down-or up-regulated by A-CEBP overexpression. Among the skeletal development-related genes, Mmp9, Pax1, Sox11, and Myf6 were downregulated more than 10 fold (Supplemental Table S1 ). Mmp9 is an inflammatory mediator during the development of cardiovascular events (6), and is involved with rheumatoid arthritis and osteoarthritis (3, 23). Pax1 regulates development of axial skeleton (41), and Sox11 contributes to GDF5 induction in joint maintenance (18). The marked downregulation by A-CEBP may indicate that C/EBP family members may be indispensable for expression of these genes in chondrocytes. Meanwhile, A-CEBP upregulated essential molecules in chondrocyte differentiation including Ihh, Frzb, Wnt7a, and Fgfr3 (Supplemental Table S4 ), implying that these genes are suppressed by C/EBPs. The diverse regulations of the target molecules may be a major obstruction to knowing the perspective of C/ EBP functions in chondrocytes. Cell proliferation was suppressed by C/EBPα, C/ EBPβ, and C/EBPδ, and accelerated by A-CEBP (Fig. 2C, 4C ). These data are consistent with the found that aggrecan is also regulated by C/EBPs. Similarly to the alteration of Col2a1, that of aggrecan by C/EBPs or A-CEBP was larger than that of Sox9, indicating that aggrecan transcription may be repressed both directly by C/EBP proteins and also indirectly via Sox9 regulation. The gene ontology analysis showed a large number of inflammation-related molecules including chemokines and interleukins (Supplemental Table S7 , S8). C/EBPβ has been known as a potent regulator of the immune response, and some of them had been identified as C/EBP dependent-genes (15). In chondrocytes, C/EBPβ mediates the induction of CCL3 and CCL4 by . The present data further indicate that various inflammatory cytokines are regulated by C/EBPs in chondrocytes. C/EBP family members may be involved with pathophysiology in inflammatory joint disorders, such as rheumatoid arthritis. Additionally, many apoptosis-related genes were identified by the present microarray analysis (Supplemental Table S9 , S10), suggesting that C/EBPs may be involved with regulation of cell survival in chondrocytes under pathophysiological conditions, as well as in hematopoietic cells, renal cells, hepatocytes, and various cancer cells (5, 10, 19, 32) . Considering that the C/EBPs suppress anabolic marker genes and enhance catabolic marker genes, inflammation-related genes and apoptosis-related genes, inhibition of C/EBP functions may be an effective treatment for a wide range of joint diseases.
In conclusion, we have presented various regulations of chondrocyte differentiation by C/EBP family members. Altered gene expressions by A-CEBP indicate that their regulations are mediated by a large number of target molecules. Further research on C/EBPs will contribute to elucidation of molecular mechanisms underlying skeletal development, osteoarthritis, and joint disorders in inflammatory diseases. 
